Summary
BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Reasons to Buy:
Note: Some sections may be missing if data is unavailable for the company
BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BTG Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
BTG Plc Company OverviewBTG Plc Company Snapshot
BTG Plc Pipeline Products and Ongoing Clinical Trials Overview
BTG Plc – Pipeline Analysis Overview
Business Description
BTG Plc - Key Facts
BTG Plc - Major Products and Services
BTG Plc Pipeline Products by Development Stage
BTG Plc Ongoing Clinical Trials by Trial Status
BTG Plc Pipeline Products Overview
CellBead - Neuro
CellBead - Neuro Product Overview
Cryotherapy Ablation System - Bone and Soft Tissue
Cryotherapy Ablation System - Bone and Soft Tissue Product Overview
Cryotherapy Ablation System - Liver Metastasis
Cryotherapy Ablation System - Liver Metastasis Product Overview
Cryotherapy Ablation System - Lung Metastasis
Cryotherapy Ablation System - Lung Metastasis Product Overview
DC Bead
DC Bead Product Overview
DC Bead Clinical Trial
DC Bead M1
DC Bead M1 Product Overview
DC Bead M1 Clinical Trial
EKOS Control Unit - New
EKOS Control Unit - New Product Overview
EkoSonic Endovascular System
EkoSonic Endovascular System Product Overview
EkoSonic Endovascular System Clinical Trial
Ibuprofen Bead
Ibuprofen Bead Product Overview
LC Bead LUMI
LC Bead LUMI Product Overview
LC Bead LUMI Clinical Trial
PARAGON Bead
PARAGON Bead Product Overview
PneumRx RePneu Coil System
PneumRx RePneu Coil System Product Overview
PneumRx RePneu Coil System Clinical Trial
TheraSphere - mCRC
TheraSphere - mCRC Product Overview
TheraSphere - mCRC Clinical Trial
Varithena - Aesthetic Leg Veins
Varithena - Aesthetic Leg Veins Product Overview
Vetex Thrombectomy Device
Vetex Thrombectomy Device Product Overview
Vetex Thrombectomy Device Clinical Trial
BTG Plc - Key Competitors
BTG Plc - Key Employees
BTG Plc - Key Employee Biographies
BTG Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
BTG Plc,
Recent Developments
Jul 19, 2018: Jeffrey Newman Law Announces $11.5 Million Settlement In Whistleblower Fraud Case Against Medical Device Distributor AngioDynamics For Selling Gelsphere Device For Unapproved Chemotherapy Eluting Purposes
Jun 15, 2018: Result Of FDA Advisory Committee Vote On Elevair For The Treatment Of Severe Emphysema
Jun 11, 2018: ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx Endobronchial Coil System
May 15, 2018: BTG: Final Results For year ended 31 March
Apr 27, 2018: OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions
Apr 04, 2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program
Mar 27, 2018: Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy With the CyberKnife System
Feb 06, 2018: OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS Therapy For Pulmonary Embolism
Dec 14, 2017: Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS Therapy Protocols for Pulmonary Embolism
Dec 12, 2017: Northwestern University adopts Y90 TARE with TheraSphere as first-line treatment for HCC
Appendix
Methodology
About
Contact Us
Disclaimer
List of Tables
BTG Plc Pipeline Products and Ongoing Clinical Trials Overview
BTG Plc Pipeline Products by Equipment Type
BTG Plc Pipeline Products by Indication
BTG Plc Ongoing Clinical Trials by Trial Status
BTG Plc, Key Facts
BTG Plc, Major Products and Services
BTG Plc Number of Pipeline Products by Development Stage
BTG Plc Pipeline Products Summary by Development Stage
BTG Plc Ongoing Clinical Trials by Trial Status
BTG Plc Ongoing Clinical Trials Summary
CellBead - Neuro - Product Status
CellBead - Neuro - Product Description
Cryotherapy Ablation System - Bone and Soft Tissue - Product Status
Cryotherapy Ablation System - Bone and Soft Tissue - Product Description
Cryotherapy Ablation System - Liver Metastasis - Product Status
Cryotherapy Ablation System - Liver Metastasis - Product Description
Cryotherapy Ablation System - Lung Metastasis - Product Status
Cryotherapy Ablation System - Lung Metastasis - Product Description
DC Bead - Product Status
DC Bead - Product Description
DC Bead - Phase 4, to Assess Time to Progression (TTP) and Safety Profile of Doxorubicin-Eluting-Bead Embolization(DEBDOX) in Patients with Advanced HCC
DC Bead - Safety and Efficacy of Drug-eluting Beads Trans-arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan: SERENADE-T
DC Bead M1 - Product Status
DC Bead M1 - Product Description
DC Bead M1 - Efficacy and Tolerability of Doxorubicin-eluting DC Bead M1 for Hepatocellular Carcinoma (HCC)
EKOS Control Unit - New - Product Status
EKOS Control Unit - New - Product Description
EkoSonic Endovascular System - Product Status
EkoSonic Endovascular System - Product Description
EkoSonic Endovascular System - Retrospective and Prospective International Ekosonic Registry of the Treatment and Clinical Outcomes of Patients with Pulmonary Embolism
EkoSonic Endovascular System - Study of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in the Treatment of Acute Submassive Pulmonary Embolism
EkoSonic Endovascular System - Submassive Pulmonary Embolism Experience with EKOS
Ibuprofen Bead - Product Status
Ibuprofen Bead - Product Description
LC Bead LUMI - Product Status
LC Bead LUMI - Product Description
LC Bead LUMI - A Phase II Study Using LC Bead LUMI Radio-opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment with Transarterial Embolization (TAE) Alone or Combined with Thermal Ablation
LC Bead LUMI - A Window of Opportunity Study of Vandetanib-eluting Radiopaque Embolic Beads (BTG-002814) in Patients with Resectable Liver Malignancies: VEROnA
LC Bead LUMI - LC Bead LUMI for Prostatic Artery Embolization: A Pilot Study
PARAGON Bead - Product Status
PARAGON Bead - Product Description
PneumRx RePneu Coil System - Product Status
PneumRx RePneu Coil System - Product Description
PneumRx RePneu Coil System - A Randomized Controlled Study of PneumRx Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema
PneumRx RePneu Coil System - Changes in Lung Physiology and Cardiac Performance in Patients with Emphysema Post Bilateral RePneu Coil Treatment
PneumRx RePneu Coil System - Crossover From IDE Trial CLN0009, Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study, IDE G
PneumRx RePneu Coil System - Identifying Responders and Exploring Mechanisms of Action of the Endobronchial Coil Treatment for Emphysema
PneumRx RePneu Coil System - Lung Volume Reduction Coil Treatment in Patients with Emphysema: RENEW Study
PneumRx RePneu Coil System - Post Market Observational, Prospective, Multi-center Registry Using the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) System
TheraSphere - mCRC - Product Status
TheraSphere - mCRC - Product Description
TheraSphere - mCRC - A Phase III Clinical Trial Evaluating Therasphere in Patients with Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
TheraSphere - mCRC - RadioEmbolization for the Advancement of Y90 Glass Microspheres Registry
Varithena - Aesthetic Leg Veins - Product Status
Varithena - Aesthetic Leg Veins - Product Description
Vetex Thrombectomy Device - Product Status
Vetex Thrombectomy Device - Product Description
Vetex Thrombectomy Device - The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation
BTG Plc, Key Employees
BTG Plc, Key Employee Biographies
BTG Plc, Subsidiaries
Glossary
List of Figures
BTG Plc Pipeline Products by Equipment Type
BTG Plc Pipeline Products by Development Stage
BTG Plc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Transgene SA
- Sirtex Medical Ltd
- Merit Medical Systems Inc
- Immupharma Plc
- F. Hoffmann-La Roche Ltd
- CeloNova BioSciences Inc
- Baxter International Inc
